🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study, is studying the combination of cabozantinib and nivolu...
Status
Completed
Location
Boston Medical Center
Start Date
2019-12-26
Trial ID
NCT04197310
Treatments Being Tested
Lung cancer is the number one cancer killer in Kentucky and has a very high...
Status
Completed
Location
Hazard ARH Regional Medical Center
Start Date
2004-11
Trial ID
NCT00596310
Treatments Being Tested
Exploring the precise medicine of patients with primary hepatobiliary cance...
Status
Recruiting
Location
Hepatic Surgery Center, Tongji Hospital, Huazhong University of Science and Technology
Start Date
2020-05-01
Trial ID
NCT05520788
Treatments Being Tested
This study aims to implement two interventions to determine the most effect...
Status
Not Yet Recruiting
Location
Danfa Community
Start Date
2026-10-01
Trial ID
NCT07745517
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
The purpose of this study is to assess whether a system that couples automa...
Status
Completed
Location
Walter Reed Army Medical Center
Start Date
2003-10
Trial ID
NCT00658190
This mixed methods study evaluates the effectiveness and feasibility of a m...
Status
Enrolling By Invitation
Location
RWJBarnabas Health - Robert Wood Johnson University Hospital
Start Date
2022-11-01
Trial ID
NCT05785780
Treatments Being Tested
Cervical cancer is the most common cancer in women under 35 years and is a ...
Status
Completed
Location
Department of Surgery and Cancer, St Mary's Campus, Praed Street, Imperial College London
Start Date
2015-02
Trial ID
NCT02363088
This research is being done to study the safety and feasibility of implanti...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-12-01
Trial ID
NCT05700461
Treatments Being Tested
To evaluate the efficacy and safety of Hetrombopag in secondary prevention ...
Status
Not Yet Recruiting
Location
Jiangsu Cancer Hospital
Start Date
2025-08-01
Trial ID
NCT07101627
Treatments Being Tested